2013•Guide of China MedicineRequires access

Clinical Effect Observation of Spironolactone Combined with Benazepri in Treatment of 47 Cases with Chronic Congestive Heart Failure

Wang Lin-hu

Open publisher page 0 citations

Abstract

Objective To explore the clinical effect of spironolactone combined with benazepri in treatment of chronic congestive heart failure. Methods 94 patients with chronic congestive heart failure in our hospital were randomly divided into spironolactone combined with benazepri treatment group(observation group) and benazepri treatment group(control group), 47 cases in each group, compared the clinical effect of patients in two groups. Results The total effective rate of patients in observation group was 91.5%, significantly higher than that in control group(74.5%), there was significant difference between two groups(P0.05). There were no obvious adverse reactions during treatment. Conclusion Taking spironolactone combined with benazepri in the treatment of chronic congestive heart failure has effective clinical effect, worthy of further clinical application.

About this research paper

What this paper is about

Objective To explore the clinical effect of spironolactone combined with benazepri in treatment of chronic congestive heart failure. Methods 94 patients with chronic congestive heart failure in our hospital were randomly divided into spironolactone combined with benazepri treatment group(observation group) and benazepri treatment group(control group), 47 cases in each group, compared the clinical effect of patients in two groups. Results The total effective rate of patients in observation group was 91.5%, significantly higher than that in control group(74.5%), there was significant difference between two groups(P0.05). There were no obvious adverse reactions during treatment. Conclusion Taking spironolactone combined with benazepri in the treatment of chronic congestive heart failure has effective clinical effect, worthy of further clinical application.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the clinical effect of spironolactone combined with benazepri in treatment of chronic congestive heart failure. Methods 94 patients with chronic congestive heart failure in our hospital were randomly divided into spironolactone combined with benazepri treatment group(observation group) and benazepri treatment group(control group), 47 cases in each group, compared the clinical effect of patients in two groups. Results The total effective rate of patients in observation group was 91.5%, significantly higher than that in control group(74.5%), there was significant difference between two groups(P0.05). There were no obvious adverse reactions during treatment. Conclusion Taking spironolactone combined with benazepri in the treatment of chronic congestive heart failure has effective clinical effect, worthy of further clinical application.

Key concepts: Spironolactone, Medicine, Heart failure, Internal medicine, Clinical efficacy, Significant difference, Treatment and control groups, Cardiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Effect Observation of Spironolactone Combined with Benazepri in Treatment of 47 Cases with Chronic Congestive Heart Failure — Research Paper | ScholarLens